<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02700854</url>
  </required_header>
  <id_info>
    <org_study_id>1Ped-AsphHENRIC001</org_study_id>
    <nct_id>NCT02700854</nct_id>
  </id_info>
  <brief_title>Hypoxic-Ischemic Encephalopathy Therapy Optimization in Neonates for Better Neuroprotection With Inhalative CO2</brief_title>
  <acronym>HENRIC</acronym>
  <official_title>Hypoxic-Ischemic Encephalopathy Therapy Optimization for Better Neuroprotection With Inhalative CO2 in Asphyxiated, Cooled, Mechanically Ventilated Neonates at Risk for Hypocapnia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Semmelweis University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Semmelweis University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This is a Phase I, open-label, single center trial to evaluate the feasibility and safety of
      low concentration CO2 gas mixture (5% CO2 + 95% air) inhalation in asphyxiated, cooled,
      mechanically ventilated newborns at risk of hypocapnia with The hypothesis is that
      hypocapnia, which is driven by hyperventilation in the presence of metabolic acidosis, is
      deleterious to the injured brain and can be safely avoided with low concentration CO2
      inhalation.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Specific aims:

        1. To test the feasibility of low concentration inhalative CO2 gas mixture (5% CO2 + 95%
           air) administration to achieve a desired range of pCO2 of 40-60 mmHg in asphyxiated,
           cooled, mechanically ventilated newborns at risk of hypocapnia with moderate to severe
           hypoxic-ischemic encephalopathy.

        2. To test the safety of CO2 gas mixture (5% CO2 + 95% air) inhalation in asphyxiated,
           cooled, mechanically ventilated newborns at risk of hypocapnia with moderate to severe
           hypoxic-ischemic encephalopathy.

      Term infants (≥ 36 weeks of gestation) will have to be at risk of hypocapnia to be eligible,
      as defined by a temperature corrected pCO2 ≤ 40 mmHg in blood gas analysis, at any time
      within six hours of life.

      The gas mixture will be administered through patient circuits in conventional ventilators.
      Administered CO2 level will be closely monitored at the inhalation circuit (constant 5% = 36
      mmHg). Blood gas samples will be taken hourly to ensure targeted and tolerable pCO2 levels.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>February 2016</start_date>
  <completion_date type="Anticipated">February 2020</completion_date>
  <primary_completion_date type="Anticipated">September 2017</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Percentage of time spent in the desired pCO2 range of 40-60 mmHg (temp. corrected) during CO2 inhalation.</measure>
    <time_frame>3 days</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of seizures, either detected clinically or by amplitude integrated EEG monitoring</measure>
    <time_frame>Within one week</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time until the end point of metabolic acidosis (BE &gt; -5 mmol/L)</measure>
    <time_frame>During CO2 inhalation (max. 12 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Time until the end point of acidosis (pH &gt; 7.25)</measure>
    <time_frame>During therapeutic hypothermia (max. 72 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Severe hypotension (mean arterial pressure less than 25 mmHg), despite full inotrope support and volume replacement.</measure>
    <time_frame>During therapeutic hypothermia (max. 72 hours)</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Intracranial haemorrhage detected by MRI</measure>
    <time_frame>Within seven days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Reduction in Lac/NAA ratio on magnetic resonance spectroscopy</measure>
    <time_frame>Within seven days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Preserved fractional anisotropy measured on diffusion weighted MRI</measure>
    <time_frame>Within seven days</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Death</measure>
    <time_frame>Within one month</time_frame>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">10</enrollment>
  <condition>Hypoxic-Ischaemic Encephalopathy</condition>
  <condition>Perinatal Asphyxia</condition>
  <condition>Hypocapnia</condition>
  <arm_group>
    <arm_group_label>5% carbon-dioxide inhalation</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>5% carbon-dioxide will be administered through patient circuits to asphyxiated, cooled, mechanically ventilated newborns at risk for hypocapnia</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>5% carbon-dioxide inhalation</intervention_name>
    <description>5% CO2 (36 mmHg) and 95% air gas mixture inhalation, for a maximum of 12 hours or until metabolic acidosis recovery occurs as measured by BE &gt; -5 mmol/L in arterial blood gas samples</description>
    <arm_group_label>5% carbon-dioxide inhalation</arm_group_label>
    <other_name>N-Carbogen</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  At any time within six hours of life the temperature corrected pCO2 is less than or
             equal to 40 mmHg after the parameters of mechanical ventilation is set according to
             standard protocol (SIMV+VG 5ml/kg, fr 20/min, PEEP 5 H20cm, Ti 0,35-0,45 sec).

          -  Moderate hypoxic- ischaemic encephalopathy, fulfilling TOBY criteria (A, B, C).

          -  ≥ 36. gest. week

          -  &lt; 6th hours of life

          -  Hypothermia treatment

          -  Parental consent form

          -  Spontaneous breathing

          -  Endotracheal intubation

          -  AUC, VUC in place

        Exclusion Criteria:

          -  Major birth defect

          -  Meconium aspiration syndrome

          -  Need for combined catecholamine therapy

          -  FiO2 &gt; 40%

          -  Htc &lt; 35%

          -  Acid-base status: pH &lt; 6.8, lactate &gt; 15mM

          -  Excessive bicarbonate administration during initial stabilization (&gt; 1mmol/kg)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>6 Hours</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Miklós Szabó, MD, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Semmelweis University, 1st Department of Pediatrics</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Enikő Szakmár, MD</last_name>
    <phone>+36307488941</phone>
    <email>drszakmareniko@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Ágnes Jermendy, MD, PhD, MPH</last_name>
    <phone>+36204600798</phone>
    <email>jermendy@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Semmelweis University, 1st Department of Pediatrics</name>
      <address>
        <city>Budapest</city>
        <zip>1085</zip>
        <country>Hungary</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Viktória Ollé</last_name>
      <phone>+36 (1) 3343186 x 52620</phone>
      <email>titkarsag.gyer1@med.semmelweis-univ.hu</email>
    </contact>
  </location>
  <location_countries>
    <country>Hungary</country>
  </location_countries>
  <reference>
    <citation>Laffey JG, Kavanagh BP. Hypocapnia. N Engl J Med. 2002 Jul 4;347(1):43-53. Review.</citation>
    <PMID>12097540</PMID>
  </reference>
  <reference>
    <citation>Pappas A, Shankaran S, Laptook AR, Langer JC, Bara R, Ehrenkranz RA, Goldberg RN, Das A, Higgins RD, Tyson JE, Walsh MC; Eunice Kennedy Shriver National Institute of Child Health and Human Development Neonatal Research Network. Hypocarbia and adverse outcome in neonatal hypoxic-ischemic encephalopathy. J Pediatr. 2011 May;158(5):752-758.e1. doi: 10.1016/j.jpeds.2010.10.019. Epub 2010 Dec 10.</citation>
    <PMID>21146184</PMID>
  </reference>
  <reference>
    <citation>Klinger G, Beyene J, Shah P, Perlman M. Do hyperoxaemia and hypocapnia add to the risk of brain injury after intrapartum asphyxia? Arch Dis Child Fetal Neonatal Ed. 2005 Jan;90(1):F49-52.</citation>
    <PMID>15613575</PMID>
  </reference>
  <reference>
    <citation>Azzopardi DV, Strohm B, Edwards AD, Dyet L, Halliday HL, Juszczak E, Kapellou O, Levene M, Marlow N, Porter E, Thoresen M, Whitelaw A, Brocklehurst P; TOBY Study Group. Moderate hypothermia to treat perinatal asphyxial encephalopathy. N Engl J Med. 2009 Oct 1;361(14):1349-58. doi: 10.1056/NEJMoa0900854. Erratum in: N Engl J Med. 2010 Mar 18;362(11):1056.</citation>
    <PMID>19797281</PMID>
  </reference>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 24, 2016</study_first_submitted>
  <study_first_submitted_qc>March 4, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 7, 2016</study_first_posted>
  <last_update_submitted>March 16, 2017</last_update_submitted>
  <last_update_submitted_qc>March 16, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">March 17, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Semmelweis University</investigator_affiliation>
    <investigator_full_name>Ágnes Jermendy</investigator_full_name>
    <investigator_title>assistant lecturer</investigator_title>
  </responsible_party>
  <keyword>Hypothermia treatment</keyword>
  <keyword>Hypocapnia</keyword>
  <keyword>Inhaled CO2</keyword>
  <keyword>Neuroprotection</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Ischemia</mesh_term>
    <mesh_term>Brain Diseases</mesh_term>
    <mesh_term>Hypoxia</mesh_term>
    <mesh_term>Brain Ischemia</mesh_term>
    <mesh_term>Hypoxia-Ischemia, Brain</mesh_term>
    <mesh_term>Asphyxia</mesh_term>
    <mesh_term>Hypocapnia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

